Title
Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study
Date Issued
01 August 2021
Access level
open access
Resource Type
journal article
Author(s)
Seiglie J.A.
Serván-Mori E.
Manne-Goehler J.
Meigs J.B.
Sosa-Rubí S.G.
Silverman-Retana O.
Wexler D.J.
Wirtz V.J.
CRÓNICAS, Centro de Excelencia en Enfermedades Crónicas
Publisher(s)
Elsevier Ireland Ltd
Abstract
Aims: We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes. Methods: We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 1:1 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes. Results: In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (1:1 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI: 1.08–1.10]). Conclusions: Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.
Volume
178
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-85113144574
PubMed ID
Source
Diabetes Research and Clinical Practice
ISSN of the container
01688227
Sponsor(s)
We thank the Dirección General de Epidemiología for their extraordinary efforts in collecting individual-level data on COVID-19 cases throughout Mexico and for providing open access to this invaluable resource. OSR received support provided by the Steno Diabetes Center Aarhus (SDCA), which is partially funded by an unrestricted donation from the Novo Nordisk Foundation. We dedicate this manuscript to our friend, colleague, and co-author, Sandra G. Sosa-Rubí, who passed away in March 2021.
Jacqueline Seiglie was supported by grant number T32DK007028 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and by grant number 5KL2TR002542-03 (Harvard Catalyst). Jennifer Manne-Goehler was supported by Grant Number K23DK125162 from the NIDDK.
We thank the Dirección General de Epidemiología for their extraordinary efforts in collecting individual-level data on COVID-19 cases throughout Mexico and for providing open access to this invaluable resource. OSR received support provided by the Steno Diabetes Center Aarhus (SDCA), which is partially funded by an unrestricted donation from the Novo Nordisk Foundation. We dedicate this manuscript to our friend, colleague, and co-author, Sandra G. Sosa-Rubí, who passed away in March 2021.
Sources of information:
Directorio de Producción Científica
Scopus